Article Information
History
- January 23, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Todd C. Lee, MD MPH FIDSA1,2,3,*,
- Srinivas Murthy, MD4,
- Olivier Del Corpo, MD MSc5,
- Julien Senécal, BSc5,
- Guillaume Butler-Laporte, MD3,
- Zahra N Sohani, MD PhD1,
- James M. Brophy, MD PhD3,7 and
- Emily G. McDonald, MD MSc2,6
- 1Division of Infectious Diseases, Department of Medicine, McGill University, Montréal, Canada
- 2Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montréal, Canada
- 3Department of Epidemiology, Occupational Health, and Biostatistics, McGill University, Montréal, Canada
- 4Department of Pediatrics, University of British Columbia, Vancouver, Canada
- 5Faculty of Medicine and Health Sciences, McGill University, Montréal, Canada
- 6Division of General Internal Medicine, Department of Medicine, McGill University, Montréal, Canada
- 7Division of Cardiology, Department of Medicine, McGill University, Montréal, Canada
- ↵*Corresponding author:
Dr. Todd C. Lee, Royal Victoria Hospital, 1001 Decarie Blvd Room E5.1820, Montréal, QC Canada H4A3J1, Todd.lee{at}mcgill.ca, Phone XXX Fax: XXX
Posted January 23, 2022.
Remdesivir for the Treatment of COVID-19: An Updated Systematic Review and Meta-Analysis
